首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1532495

膽固醇測試服務市場規模- 按測試類型（總膽固醇、HDL、LDL、三酸甘油酯）、產品類型（測試套件、試紙）、應用（心血管疾病、糖尿病、肥胖）、年齡層、服務提供者和全球預測，2024 年 - 2032

Cholesterol Testing Services Market Size - By Test Type (Total Cholesterol, HDL, LDL, Triglyceride), Product Type (Testing Kits, Strips), Application (Cardiovascular Disease, Diabetes, Obesity), Age Group, Service Provider & Global Forecast, 2024 - 2032

出版日期: 2024年05月21日 | 出版商:

Global Market Insights Inc. | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於心血管疾病 (CVD) 盛行率不斷上升以及人們健康意識不斷增強，膽固醇檢測服務市場規模預計 2024 年至 2032 年複合年成長率為 8.1%。根據世界衛生組織的數據，CVD 是世界上最主要的死亡原因，每年奪走約 1,790 萬人的生命。隨著肥胖、糖尿病和高血壓等與生活方式相關的疾病變得普遍，人們更傾向於定期進行膽固醇篩檢，以主動管理自己的健康。

更準確、更快速和方便用戶使用的膽固醇檢測方法的開發也提高了患者的可及性和便利性，鼓勵更頻繁的檢測。將膽固醇檢測服務納入常規健康檢查和健康計劃（無論是在臨床環境中還是透過家庭檢測套件）也將擴大其可用性和吸引力。

市場分為測試類型、產品類型、應用、年齡層、服務提供者和地區。

根據測試類型，三酸甘油酯測試領域的膽固醇測試服務市場預計到 2032 年將大幅成長。高三酸甘油酯水平通常與心臟病、中風和其他代謝紊亂的風險增加有關，因此監測對於預防保健至關重要。

由於高血脂症盛行率不斷上升，高血脂應用領域的膽固醇檢測服務產業將在 2024 年至 2032 年期間產生可觀的收入。管理高血脂需要定期監測這些脂質水平，以預防心血管疾病和其他相關的健康併發症。隨著越來越多的人被診斷出患有高血脂症，對膽固醇檢測服務的需求也將增加，以促進早期發現和持續管理。

由於心血管疾病和生活方式相關健康問題日益流行，亞太地區膽固醇檢測服務市場預計到 2032 年將呈現良好的成長速度。快速的城市化和飲食習慣的改變導致人口膽固醇水平升高，進一步需要定期監測膽固醇。促進常規健康檢查的政府措施和公共衛生運動也促進了區域產業的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 心血管疾病盛行率上升
  - 預防保健意識不斷增強
  - 老年人口增加
- 產業陷阱與挑戰
  - 監管和品質保證挑戰
  - 與測試服務相關的高成本
成長潛力分析
技術景觀
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按測試類型，2021 - 2032 年

主要趨勢
總膽固醇測試
高密度脂蛋白（HDL）膽固醇測試
低密度脂蛋白（LDL）膽固醇測試
三酸甘油酯測試
其他測試

第 6 章：市場估計與預測：按產品類型，2021 - 2032 年

主要趨勢
測試套件
測試條
其他產品類型

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
心血管疾病
糖尿病
肥胖
高血脂症
其他應用

第 8 章：市場估計與預測：按年齡分類，2021 - 2032

主要趨勢
老年科
成人
兒科

第 9 章：市場估計與預測：按服務提供者分類，2021 - 2032 年

主要趨勢
醫院和診所
診斷實驗室
門診護理中心
其他服務提供者

第 10 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 11 章：公司簡介

Abbott Laboratories
Accu Reference Medical Lab, LLC
Atherotech Diagnostics Lab
Bio-Reference Laboratories, Inc.
Boston Heart Diagnostics Corporation
Cell Biolabs Inc.
Clinical Reference Laboratory, Inc.
Eurofins Scientific
Mayo Clinic Laboratories
Quest Diagnostics Incorporated
Randox Laboratories Limited
Sonic Healthcare Limited
SpectraCell Laboratories Inc.
SYNLAB Holding Deutschland GmbH
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 9548

Cholesterol testing services market size is estimated to register 8.1% CAGR from 2024 to 2032 driven by the increasing prevalence of cardiovascular diseases (CVDs) and the growing health awareness among the population. As per WHO, CVDs are the world's leading cause of death, claiming approximately 17.9 million lives annually. As lifestyle-related conditions, such as obesity, diabetes, and high blood pressure have become common, individuals are more inclined to seek regular cholesterol screenings to manage their health proactively.

The development of more accurate, rapid, and user-friendly cholesterol testing methods is also enhancing the accessibility and convenience for patients, encouraging more frequent testing. The integration of cholesterol testing services into routine health check-ups and wellness programs, both in clinical settings and through home testing kits will also broaden their availability and appeal.

The market is classified into test type, product type, application, age group, service provider, and region.

Based on test type, the cholesterol testing services market from the triglyceride tests segment is anticipated to witness substantial growth through 2032. This is due to the strong need to provide crucial insights into the overall lipid profile, which is essential for comprehensive cardiovascular risk assessment. High triglyceride levels are often associated with increased risk of heart disease, stroke, and other metabolic disorders, making monitoring vital for preventive healthcare.

Cholesterol testing services industry from the hyperlipidemia application segment will generate notable revenue during 2024-2032 owing to the rising prevalence of hyperlipidemia. Managing hyperlipidemia requires regular monitoring of these lipid levels to prevent cardiovascular diseases and other associated health complications. As more individuals are diagnosed with hyperlipidemia, the demand for cholesterol testing services will also increase to facilitate early detection and ongoing management.

Asia Pacific cholesterol testing services market is slated to depict decent growth rate through 2032 backed by the increasing prevalence of cardiovascular diseases and lifestyle-related health issues. Rapid urbanization and changing dietary habits are contributing to higher cholesterol levels among the population, further necessitating regular cholesterol monitoring. Government initiatives and public health campaigns for promoting routine health screenings are also adding to the regional industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of cardiovascular diseases
  - 3.2.1.2 Growing awareness of preventive healthcare
  - 3.2.1.3 Increasing geriatric population
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Regulatory and quality assurance challenges
  - 3.2.2.2 High cost associated with the testing services
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Total cholesterol tests
5.3 High density lipoprotein (HDL) cholesterol tests
5.4 Low density lipoprotein (LDL) cholesterol tests
5.5 Triglyceride tests
5.6 Other tests

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Testing kits
6.3 Testing strips
6.4 Other product types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Cardiovascular diseases
7.3 Diabetes
7.4 Obesity
7.5 Hyperlipidemia
7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Geriatric
8.3 Adult
8.4 Pediatric

Chapter 9 Market Estimates and Forecast, By Service Provider, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Hospitals and clinics
9.3 Diagnostic laboratories
9.4 Ambulatory care centers
9.5 Other service providers

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 Saudi Arabia
- 10.6.2 South Africa
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa